Dr. Joanne Lorraine Blum M.D.
Oncologist | Medical Oncology
3410 Worth St Dallas TX, 75246Rating
4/5
About
Joanne L. Blum, M.D., Ph.D., FACP specializes in medical oncology and hematology. She is a Diplomate of the American Board of Internal Medicine with subspecialty certifications in medical oncology and ...
Education and Training
Univ of Md Sch of Med, Baltimore Md 1979
University of Maryland School of Medicine 1979
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.
- Family environments of women seeking BRCA1/BRCA2 genetic mutation testing: an exploratory analysis.
- Capecitabine/Taxane combination therapy: evolving clinical utility in breast cancer.
- Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
- Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers.
- Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers.
- Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine.
- Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
- Association of age and overall survival in capecitabine-treated patients with metastatic breast cancer in clinical trials.
- Genetic variation in IGF2 and HTRA1 and breast cancer risk among BRCA1 and BRCA2 carriers.
- Dose-adjusting capecitabine minimizes adverse effects while maintaining efficacy: a retrospective review of capecitabine for metastatic breast cancer.
- Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
- A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.
- Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer.
- Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers.
Awards
- 2005-2011 Texas Super Doctors
Treatments
- Breast Cancer, Cancer Genetics, Hereditary Cancer
- Anemia
- Osteoporosis
- Skin Cancer
- Breast Cancer
- Lung Cancer
- Acute Myeloid Leukemia (aml)
- Lymphoma
- Ovarian Cancer
- Multiple Myeloma
- Leukemia
- Dermal Aesthetics
- Extra Corporeal Shockwave Therapy
Dr. Joanne Lorraine Blum M.D.'s Practice location
Practice At 3410 Worth St
3410 Worth St -Dallas, TX 75246Get Direction
Practice At 3535 Worth St
3535 Worth St -Dallas, TX 75246Get Direction
Dr. Joanne Lorraine Blum M.D.'s reviews
Write ReviewPatient Experience with Dr. Blum
Recommended Articles
![]()
Healing and Recovery After Breast Cancer DiagnosisWhat was (or would be) the first thoughts and emotions you would experience if a doctor ever looked you square in your eyes and said, “I’m sorry but you have breast cancer”?For Mary, diagnosed when she was in her late 30s, her first thought was “no I don’t,” and of course her first words...
![]()
Cancer in the Lymph NodesWhat is Lymphoma?Lymphoma is a type of cancer which affects the lymphatic system. The lymphatic system includes the spleen, bone marrow, thymus gland and lymph nodes (or lymph glands). When a person has lymphoma, all these body parts, among others, are affected.The lymphatic system is the body’s...
![]()
Brave Teenager Shaves Head for Ovarian Cancer AwarenessAfter her friend died from ovarian cancer, Ruby was devastated. However, she committed herself to raising awareness in a very brave way.Shave it offAt only thirteen years old, Ruby thought of a way to raise awareness for ovarian cancer that she was sure would grab people's attention. She decided...
![]()
Breast Cancer Death Rate Has Dropped Dramatically in the USThe results from a 2015 breast cancer study are in, and the news is great!The study shows there is a 39% lower death rate in the US from breast cancer. And that there has been a steady decline of such deaths since 1989. The reduction in breast cancer-related deaths is reported to be the result of...
![]()
Is a Mastectomy an Efficient Option to Treat Breast Cancer?A mastectomy refers to the surgery performed to remove the breasts, either completely or partially. This was one of the traditional methods in the treatment of breast cancer for a long time. It is also used as a method to reduce the chances of developing breast cancer for women who have a high risk...
![]()
Breastfeeding Can Lower the Risk of Ovarian CancerIf you are pregnant and at risk for ovarian cancer, consider breastfeeding your baby to greatly reduce your risk. The idea that breastfeeding reduces a woman’s risk for disease is not new. However, it is still widely unadvertised, so many women are still unaware of the other benefits of...
Nearby Providers
![]()
Dr. Jay Courtright M.D.7777 Forest Ln Dallas TX 75230![]()
Dr. Lee Drinkard MDLee Drinkard, Md, Facp Irving TX 75039![]()
Dr. Stephen E. Boswank M.D.4700 N GALLOWAY AVE MESQUITE TX 75150![]()
Larry Anderson, Jr.2201 Inwood Road Dallas Texas 75235![]()
Dr. Scott Lawrence Fleischauer MD801 Road To Six Flags W Arlington TX 76012![]()
Dr. Gerald Edelman M.D.2021 N Macarthur Blvd Irving TX 75061
Nearest Hospitals
BAYLOR HEART AND VASCULAR HOSPITALl
621 NORTH HALL STREET DALLAS TX 75226BAYLOR UNIVERSITY MEDICAL CENTERl
3500 GASTON AVE DALLAS TX 75246BAYLOR UNIVERSITY MEDICAL CENTERl
3500 GASTON AVE DALLAS TX 75246BAYLOR HEART AND VASCULAR HOSPITALl
621 NORTH HALL STREET DALLAS TX 75226